Genovate Biotechnology Co., Ltd. - Laporan Laba Rugi (TTM)

Genovate Biotechnology Co., Ltd.
TW ˙ TPEX
NT$ 22.40 ↓ -0.30 (-1.32%)
2024-10-25
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Genovate Biotechnology Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 487 473 440 417 413 434 430 439 436 439 471 503 524 529 536 523 512 511 503 502
Change (%) -2.98 -6.83 -5.39 -0.77 5.03 -0.89 1.90 -0.65 0.70 7.27 6.79 4.32 0.79 1.47 -2.52 -2.04 -0.24 -1.58 -0.14
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 284 280 263 263 273 284 288 288 282 284 296 304 314 318 321 318 315 318 319 320
Change (%) -1.38 -5.87 -0.25 3.98 4.22 1.12 0.19 -2.16 0.67 4.40 2.72 3.12 1.17 1.01 -0.85 -0.90 0.95 0.23 0.37
% of Revenue 58.19 59.15 59.76 63.01 66.02 65.51 66.84 65.73 64.72 64.70 62.97 60.57 59.87 60.09 59.82 60.85 61.55 62.29 63.43 63.76
Gross Operating Profit 204 193 177 154 140 150 143 150 154 155 174 198 210 211 215 205 197 193 184 182
Change (%) -5.22 -8.22 -13.03 -8.86 6.60 -4.72 5.34 2.26 0.75 12.54 13.72 6.17 0.23 2.17 -5.02 -3.82 -2.15 -4.56 -1.04
% of Revenue 41.81 40.85 40.24 36.99 33.98 34.49 33.16 34.27 35.28 35.30 37.03 39.43 40.13 39.91 40.18 39.15 38.45 37.71 36.57 36.24
SG&A 101 99 98 96 95 95 99 100 57 107 105 108 155 110 111 112 112 110 110 111
Change (%) -2.20 -0.75 -1.66 -0.97 0.12 3.76 1.37 -42.99 86.67 -1.70 2.52 43.86 -28.83 0.73 0.39 0.25 -1.87 0.09 0.97
% of Revenue 20.71 20.87 22.24 23.11 23.07 21.99 23.02 22.90 13.14 24.36 22.32 21.43 29.55 20.87 20.72 21.34 21.84 21.48 21.84 22.09
R&D 57 55 52 49 57 55 58 59 49 62 63 71 70 74 72 66 70 59 60 59
Change (%) -3.62 -4.57 -5.59 15.99 -3.44 4.12 2.76 -18.10 27.39 1.50 13.11 -0.88 4.55 -1.70 -8.55 5.51 -14.81 0.30 -1.27
% of Revenue 11.70 11.62 11.90 11.88 13.88 12.76 13.41 13.52 11.15 14.10 13.34 14.13 13.43 13.93 13.49 12.66 13.64 11.64 11.87 11.73
OpEx 441 433 414 408 426 435 444 448 432 453 464 483 495 502 504 496 497 487 488 490
Change (%) -1.85 -4.54 -1.26 4.27 2.27 2.08 0.79 -3.55 4.76 2.56 4.08 2.45 1.31 0.55 -1.68 0.21 -1.90 0.21 0.31
% of Revenue 90.59 91.64 93.90 98.00 102.98 100.27 103.28 102.15 99.17 103.17 98.64 96.13 94.41 94.89 94.03 94.84 97.03 95.41 97.14 97.58
Operating Income 46 39 27 8 -12 -1 -14 -9 4 -14 6 19 29 27 32 27 15 23 14 12
Change (%) -13.87 -31.95 -68.98 -247.61 -90.52 1,109.78 -33.10 -138.42 -483.07 -146.25 202.90 50.65 -7.87 18.58 -15.81 -43.52 53.86 -38.72 -15.47
% of Revenue 9.41 8.36 6.10 2.00 -2.98 -0.27 -3.28 -2.15 0.83 -3.17 1.36 3.87 5.59 5.11 5.97 5.16 2.97 4.59 2.86 2.42
Interest Expense -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -1 -1 -1
Change (%) 24.75 20.24 17.49 -14.33 -17.70 -22.31 -24.10 44.59 30.37 23.30 15.41 -16.12 -20.42 -26.79 2.06 79.29 45.63 32.69 14.72
% of Revenue -0.04 -0.05 -0.07 -0.09 -0.07 -0.06 -0.05 -0.03 -0.05 -0.06 -0.07 -0.08 -0.06 -0.05 -0.04 -0.04 -0.07 -0.10 -0.14 -0.16
Net Income 43 39 29 12 -10 0 -18 -12 3 -12 10 21 30 29 33 27 16 26 19 18
Change (%) -8.93 -25.63 -59.01 -185.02 -103.71 -4,850.54 -34.58 -125.81 -512.97 -182.16 102.78 48.57 -3.82 12.21 -17.06 -41.88 61.97 -27.60 -3.50
% of Revenue 8.73 8.19 6.54 2.83 -2.43 0.09 -4.11 -2.64 0.68 -2.81 2.15 4.08 5.82 5.55 6.14 5.22 3.10 5.03 3.70 3.58

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista